Here, our in vivo and in vitro results reveal the potential mechanism of the FABP3-mediated PPARα pathway in cardiac hypertrophy and in FAO/glycolysis balance by directly binding to PPARα, promoting its stability, and underpinning its transactivation in Mlycd and Gck. The gene discussed is PPARA; the disease is cardiac hypertrophy.